These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32679056)

  • 1. Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors.
    Gallian P; Pastorino B; Morel P; Chiaroni J; Ninove L; de Lamballerie X
    Antiviral Res; 2020 Sep; 181():104880. PubMed ID: 32679056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.
    Thompson CP; Grayson NE; Paton RS; Bolton JS; Lourenço J; Penman BS; Lee LN; Odon V; Mongkolsapaya J; Chinnakannan S; Dejnirattisai W; Edmans M; Fyfe A; Imlach C; Kooblall K; Lim N; Liu C; López-Camacho C; McInally C; McNaughton AL; Ramamurthy N; Ratcliff J; Supasa P; Sampson O; Wang B; Mentzer AJ; Turner M; Semple MG; Baillie K; ; Harvala H; Screaton GR; Temperton N; Klenerman P; Jarvis LM; Gupta S; Simmonds P
    Euro Surveill; 2020 Oct; 25(42):. PubMed ID: 33094713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
    Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
    PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.
    Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL;
    Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
    Grzelak L; Temmam S; Planchais C; Demeret C; Tondeur L; Huon C; Guivel-Benhassine F; Staropoli I; Chazal M; Dufloo J; Planas D; Buchrieser J; Rajah MM; Robinot R; Porrot F; Albert M; Chen KY; Crescenzo-Chaigne B; Donati F; Anna F; Souque P; Gransagne M; Bellalou J; Nowakowski M; Backovic M; Bouadma L; Le Fevre L; Le Hingrat Q; Descamps D; Pourbaix A; Laouénan C; Ghosn J; Yazdanpanah Y; Besombes C; Jolly N; Pellerin-Fernandes S; Cheny O; Ungeheuer MN; Mellon G; Morel P; Rolland S; Rey FA; Behillil S; Enouf V; Lemaitre A; Créach MA; Petres S; Escriou N; Charneau P; Fontanet A; Hoen B; Bruel T; Eloit M; Mouquet H; Schwartz O; van der Werf S
    Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32817357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020.
    Percivalle E; Cambiè G; Cassaniti I; Nepita EV; Maserati R; Ferrari A; Di Martino R; Isernia P; Mojoli F; Bruno R; Tirani M; Cereda D; Nicora C; Lombardo M; Baldanti F
    Euro Surveill; 2020 Jun; 25(24):. PubMed ID: 32583766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
    Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
    J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
    Ng DL; Goldgof GM; Shy BR; Levine AG; Balcerek J; Bapat SP; Prostko J; Rodgers M; Coller K; Pearce S; Franz S; Du L; Stone M; Pillai SK; Sotomayor-Gonzalez A; Servellita V; Martin CSS; Granados A; Glasner DR; Han LM; Truong K; Akagi N; Nguyen DN; Neumann NM; Qazi D; Hsu E; Gu W; Santos YA; Custer B; Green V; Williamson P; Hills NK; Lu CM; Whitman JD; Stramer SL; Wang C; Reyes K; Hakim JMC; Sujishi K; Alazzeh F; Pham L; Thornborrow E; Oon CY; Miller S; Kurtz T; Simmons G; Hackett J; Busch MP; Chiu CY
    Nat Commun; 2020 Sep; 11(1):4698. PubMed ID: 32943630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020.
    Bogogiannidou Z; Vontas A; Dadouli K; Kyritsi MA; Soteriades S; Nikoulis DJ; Mouchtouri VΑ; Koureas M; Kazakos EI; Spanos EG; Gioula G; Ntzani EE; Eleftheriou AA; Vatopoulos A; Petinaki E; Papaevangelou V; Speletas M; Tsiodras S; Hadjichristodoulou C
    Euro Surveill; 2020 Aug; 25(31):. PubMed ID: 32762796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.
    Fafi-Kremer S; Bruel T; Madec Y; Grant R; Tondeur L; Grzelak L; Staropoli I; Anna F; Souque P; Fernandes-Pellerin S; Jolly N; Renaudat C; Ungeheuer MN; Schmidt-Mutter C; Collongues N; Bolle A; Velay A; Lefebvre N; Mielcarek M; Meyer N; Rey D; Charneau P; Hoen B; De Seze J; Schwartz O; Fontanet A
    EBioMedicine; 2020 Sep; 59():102915. PubMed ID: 32747185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT).
    Meyer B; Reimerink J; Torriani G; Brouwer F; Godeke GJ; Yerly S; Hoogerwerf M; Vuilleumier N; Kaiser L; Eckerle I; Reusken C
    Emerg Microbes Infect; 2020 Dec; 9(1):2394-2403. PubMed ID: 33043818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
    Deshpande GR; Sapkal GN; Tilekar BN; Yadav PD; Gurav Y; Gaikwad S; Kaushal H; Deshpande KS; Kaduskar O; Sarkale P; Baradkar S; Suryawanshi A; Lakra R; Sugunan AP; Balakrishnan A; Abraham P; Salve P
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):82-87. PubMed ID: 32859866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic.
    Runkel S; Kowalzik F; Gehring S; Winter J; Grandt CL; Marron M; Seifert-Hitzler S; Hitzler WE
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France.
    Mattern J; Vauloup-Fellous C; Zakaria H; Benachi A; Carrara J; Letourneau A; Bourgeois-Nicolaos N; De Luca D; Doucet-Populaire F; Vivanti AJ
    PLoS One; 2020; 15(10):e0240782. PubMed ID: 33057392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.